datastreet.in

Gilead Sciences shares decline 1.36% ahead of first quarter earnings

Wall Street analysts have set a consensus EPS estimate of $1.91, reflecting a 5.5% year-over-year increase, alongside a revenue target of $6.92 billion, up 3.7% from the previous year

Source :- mint – markets Read More

Share it :

Leave a Reply

Your email address will not be published. Required fields are marked *